Professional use only — for distributors, importers and licensed clinicians. This page is not directed at patients or consumers.
980 + 1470nmCE · MDSAP · ISO 13485FDA 510(k) K241791Request pricing
Endolifting · Subdermal Laser Platform

Endolifting · Subdermal Laser System980nm + 1470nm Laser Lift System for Subdermal Skin Tightening

A professional dual-wavelength diode laser platform for controlled subdermal photothermal applications, including laser-assisted lipolysis.

FDA 510(k) K241791ISO 13485MDSAPCE

FDA 510(k) K241791 is referenced strictly within its cleared indications.

980nm + 1470nm · up to 30 W + 15 WDiode laser platform
980nm30WHemoglobin and water interaction — coagulation and controlled photothermal tissue interaction
1470nm15WSubstantially higher water absorption than 980nm — dermal and subdermal photothermal interaction
Combined outputup to 45 W
Modes
CW · Single · Repeat
Pulse width
10 ms – 1 s
Rep. rate
0.2 Hz – 20 kHz
Fiber interface
SMA 905 Open Fiber Port
Laser class
4 · IEC 60825-1 · EMC
Aiming beam
635/520nm · <5 mW
Platform familyFDA 510(k) · CE MDR
VELAS console
VELASPro-30B15D · 980 + 1470nm
FDA 510(k) K241791
LASEVIA console with articulated fiber arm
LASEVIAPlatform console · Android
CE MDR
View the full clearances — FDA 510(k) K241791 · CE · ISO 13485 · MDSAP — and what the clearance does not cover
United StatesFDA 510(k) K241791Traditional 510(k), cleared 19 March 2025, substantially equivalent. Product code GEX, Class II; 21 CFR 878.4810. VELAS Pro-30B15D is one of the seven models named in the clearance.
Quality systemISO 13485Medical device quality management system, independently audited. Certificate and scope of registration supplied on request for your market.
Audit programMDSAPAudited under the Medical Device Single Audit Program, recognized by the United States, Canada, Brazil, Australia and Japan.
European UnionCE markBoth models are CE marked. The declaration of conformity and labeling are issued by the manufacturer that built the device.

What the FDA clearance does — and does not — cover. K241791 clears seven diode laser models under product code GEX (21 CFR 878.4810, Class II). The model cleared at 980nm or 1470nm is VELAS Pro-30B15D.

Its cleared indications are surgical applications requiring vaporization, incision, excision, ablation, cutting and hemostasis or coagulation of soft tissue in conjunction with endoscopic equipment; endovascular coagulation and endovenous occlusion of the greater saphenous vein in patients with superficial vein reflux; and laser-assisted lipolysis.

Aesthetic skin tightening or lifting is not among the cleared indications for this device. Confirm the applicable clearances and permitted indications for your market with our export desk before you publish any local claim.

MANUFACTURING

Built in-house since 2005

Designed and manufactured by GigaaMed — Gigaalaser Company, Ltd. — in Wuhan, China. Over twenty years of diode laser system engineering.

OEM / ODM

Partner to laser brands since 2010

Original equipment and original design manufacturing for international laser brands, built and shipped under their label rather than ours.

DOCUMENTATION

The technical file is ours

The CE marking, ISO 13485 quality system, MDSAP audit material and the FDA 510(k) file are held and issued by the manufacturer that built the device — not forwarded by a reseller.

Technology

What is a 980nm + 1470nm Laser Lift System?

A dual-wavelength diode laser platform that delivers controlled photothermal energy below the skin surface through a fine optical fiber. Both wavelengths share one console and one fiber port, and the clinician selects the wavelength according to the treatment objective and tissue plane.

980nm

980nm diode laser

980nm is absorbed by both hemoglobin and water. It supports controlled coagulation and photothermal interaction in soft tissue, and is used across a broad range of surgical and therapeutic diode laser applications.

1470nm

1470nm laser system

1470nm has substantially higher water absorption than 980nm. That suits dermal and subdermal applications where the target is tissue water rather than pigment.

How the two wavelengths work together. The two wavelengths produce different tissue interaction characteristics. The clinician selects the wavelength according to the treatment objective, tissue plane and clinical protocol — on the same fiber port, in the same session where the protocol allows.

Clinical overview

Endolifting, in plain terms.

A minimally invasive, fiber-based laser procedure for subdermal skin tightening and facial contouring — commonly requested for the jawline, double chin, neck and under-eye area.

STEP 1 · INSERTION

Microfiber delivery

Single-use micro-optical fibers, around 0.2 to 0.3 mm, are inserted under the superficial hypodermis. The procedure is minimally invasive and fiber-based, and is performed in an office setting.

STEP 2 · ENERGY DELIVERY

Controlled subdermal photothermal energy

The platform transmits controlled thermal energy directly to the targeted subcutaneous tissue through the fiber. Wavelength and settings are selected by the treating clinician according to treatment objective, tissue plane and protocol.

STEP 3 · DUAL RESPONSE

Toning and localized fat

The thermal energy targets localized fat pockets — laser-assisted lipolysis is among the cleared indications of the platform — while producing immediate tissue toning. Confirm permitted claims for your market before you publish.

Endolifting target areas, face and body
Target areas commonly requested for Endolifting protocols — face, neck and body.

Key benefits

  • Skin tightening. The treatment shrinks connective septums and supports the production of new collagen and elastin, so the skin becomes firmer and tighter over time.
  • Localized fat reduction. The laser emulsifies localized pockets of fat — useful for sculpting the jawline and reducing a double chin.
  • Minimally invasive. A fiber-based procedure. Recovery time varies according to the treatment area and by patient.
  • Results that build. Immediate tightening can often be seen, and results typically continue to improve over 3 to 6 months as new collagen builds. Longevity varies by patient and treatment area.
Built for clinicians and distributors

Two ways to work with us.

The same platform, two different sets of questions. Pick the one that matches your role and we will send the right pack — not a generic brochure.

For clinicians

I treat patients in a clinic

Clinical information for qualified healthcare professionals.

  • Dual-wavelength platform, 980nm + 1470nm
  • Multiple fiber options on one SMA 905 port
  • Clinical information available on request
  • Training support
  • Protocol development support
For distributors

I distribute, import or private-label

Commercial and regulatory support for qualified partners.

  • OEM and private label
  • Distributor programs and territory options
  • Regulatory documentation
  • Training and technical support
  • Multiple product configurations

This page is written for distributors, importers and licensed clinicians. We do not advise patients or recommend practitioners — if you are seeking treatment, please consult a qualified physician in your own area.

Platform

One platform. Multiple clinical configurations.

Configure the platform according to wavelength, fiber and application requirements. Both configurations below carry the identical 980nm + 1470nm pair at the identical rating — what differs is the console, and how far you want to take it.

ParameterEndolifting
Wavelengths980nm + 1470nm
Output30 W at 980nm / 15 W at 1470nm
Combined outputUp to 45 W
Fiber interfaceSMA 905 — open, non-proprietary
Fiber options200 / 400 / 600 / 1000 µm contact fibers, plus radial and non-contact tips
ApplicationSubdermal laser applications — skin tightening and laser-assisted lipolysis
PlatformDual-wavelength diode laser
VELAS Pro-30B15D console

VELAS Pro-30B15D

A dedicated console for laser lift and laser-assisted lipolysis procedures.

Wavelengths
980nm + 1470nm
Output
30 W at 980nm + 15 W at 1470nm — 45 W max
Pulse width
10 ms – 1 s
Rep. rate
0.2 Hz – 20 kHz
Modes
CW · Single · Repeat
Console
74 × 55 × 49 cm · 30 kg
Interface
Touchscreen · 8 languages
Screen
True-color touch screen
Software
The 8-in-1 software comes with preset parameters
Warranty
3 years · laser device
FDA
Cleared under 510(k) K241791 (Mar 2025) — incl. laser-assisted lipolysis
Suits
One indication list, a first unit, or a price-sensitive market
LASEVIA console interface

LASEVIA-BD

Platform console

The same 980 + 1470nm pair, at the identical 30 W + 15 W rating, on the LASEVIA console — portable, Android-driven, and the console family extends to further wavelengths and specialties.

Wavelengths
980nm + 1470nm · 450nm (optional)
Output
980nm 30 W + 1470nm 15 W — the identical rating as the VELAS
Pulse width
25 µs – 10 s
Rep. rate
0.05 Hz – 50 kHz
Modes
CW · Single · Repeat
Fiber port
SMA 905 · 200 / 400 / 600 / 1000 µm
Console
15 kg portable · 11.6 in Android UI
Interface
Four operator themes · presets editable
System
Smart Android system · remote service
Screen
11.6 in Android touchscreen
Software
The 8-in-1 software comes with preset parameters
Warranty
3 years · laser device
Platform
Console family extends to further wavelengths and clinical specialties
Suits
Multi-specialty clinics, treatment-menu builders, private-label brands
GBOX-15B laser console

FIRELAS-15B15D

GBOX-15B console

The FIRELAS-15B15D configuration on the GBOX-15B console — dual-wavelength output following GigaaMed’s model designation: 15 W at 980nm plus 15 W at 1470nm. Full specification sheet on request.

Model
FIRELAS-15B15D · console GBOX-15B
Wavelengths
980nm + 1470nm
Output
15 W at 980nm + 15 W at 1470nm — 30 W peak
Modes
CW · Single · Repeat
Screen
8 in touch screen
Console
5 kg · 245 × 215 × 315 mm
Software
The 8-in-1 software comes with preset parameters
Warranty
3 years · laser device
Suits
Clinics adding Endolifting alongside an existing device

Model designations follow GigaaMed’s naming convention — the letter suffix denotes wavelength: B for 980nm and D for 1470nm. So 30B15D reads as 30 W at 980nm plus 15 W at 1470nm. Specifications are configuration-dependent and subject to change — request the current specification sheet for your market. Screen sizes and warranty terms follow the same rule: the shipped specification sheet is authoritative.

Clinical applications

Where the platform is used.

The wavelength, fiber and protocol are selected according to the treatment objective, the tissue plane and the applicable local indications.

01 / SKIN TIGHTENING

Skin tightening & tissue remodeling

Minimally invasive laser treatment approaches for dermal and subdermal tissue remodeling and skin tightening — the technique known clinically as endolifting.

02 / LIPOLYSIS

Laser-assisted lipolysis

Laser-assisted lipolysis applications using controlled subdermal photothermal energy.

03 / VASCULAR & SOFT TISSUE

Vascular & soft-tissue applications

Selected soft-tissue and vascular applications according to the applicable device configuration, clinical protocol and local regulatory requirements.

Face

  • Submental
  • Neck
  • Jowl
  • Lower eyelids
  • Nasolabial folds
  • Double chin
  • Fine lines and wrinkles
  • Skin laxity

Body

  • Inner arms
  • Abdomen and peri-umbilical area
  • Inner thighs
  • Knees
  • Ankles
  • Gluteus
  • Localized adipose deposits

Patient selection and parameters are clinical decisions. Clinical applications may include patients presenting with mild-to-moderate skin laxity or localized adipose deposits, subject to appropriate clinical assessment and applicable local indications. Treatment parameters and patient selection should be determined by a qualified clinician.

Treatment parameters should be individualized by a qualified healthcare professional according to treatment area, tissue characteristics, patient factors and applicable clinical protocols.

Not every area or application listed is cleared or permitted in every market. Confirm the applicable indications and labeling for your territory before promotion or clinical use.

Clinical evidence

Three kinds of evidence, kept separate.

Regulatory clearance, published literature and manufacturer case documentation are different things. We label them separately so you can weigh them accordingly.

01 / REGULATORY EVIDENCE

FDA 510(k) K241791

The US clearance file: traditional 510(k), cleared 19 March 2025, product code GEX, 21 CFR 878.4810. It applies to the indications stated in the clearance letter — see the credentials section above for the exact scope.

02 / PUBLISHED LITERATURE

Peer-reviewed literature

Peer-reviewed literature concerning 1470nm, intralesional laser application, laser-assisted lipolysis and tissue remodeling. Study designs and parameters vary, and we do not summarize them as a single result.

03 / CASE DOCUMENTATION

Manufacturer & physician cases

Case photography attributed to a named treating physician or to our own documented procedure. This is case documentation — not controlled trial evidence — and is presented as such.

Published literature on intralesional 1470nm laser applications reports potential benefits for tissue remodeling, skin laxity and adipose-related applications; however, study designs, treatment parameters and evidence quality vary, and further controlled studies are needed.

Endolifting 1470nm neck treatment, before and after

Neck / submental area

Wavelength
1470nm
Device
Endolifting platform
Application
Skin tightening — neck and submental vectors
Protocol
Single session
Follow-up
Available to qualified clinicians on request
Attribution
Published by GigaaMed as product documentation
Laser-assisted lipolysis of the abdomen, before and after

Abdomen

Wavelength
1470nm
Device
Endolifting platform
Application
Laser-assisted lipolysis
Protocol
Pre-operative vector marking shown
Follow-up
Available to qualified clinicians on request
Attribution
Dr. A. Landette Bonfante (@dra.alandettebonfante), published by GigaaMed

Clinical outcomes vary between patients. Case results are individual and are not intended to represent typical or guaranteed results. Before-and-after photography, treatment parameters and follow-up intervals for specific cases are available to qualified distributors and clinicians on request, subject to physician authorization. No clinical claim is made for any specific patient group.

For clinicians

Clinical information and protocol support.

Endolifting is an office-based, minimally invasive procedure. A thin fiber is introduced through a micro-puncture and delivers energy along anti-gravitational vectors — heating the deep dermis and the subdermal plane to produce immediate contraction, followed by new collagen formation over the following months.

Endolifting facial treatment in progress
Facial Endolifting in progress. Anti-gravitational vectors are marked before fiber insertion; the red pilot beam marks the fiber tip position in the deep dermal plane.
Fiber selection by area
200 µm for fine, superficial applications and thin skin · 400 µm for facial and neck applications · 600 µm and larger for selected body and deeper tissue applications. All on one universal SMA 905 port.
Plane and vectors
Tunnels are oriented along anti-gravitational lines. The number of vectors is determined by the area treated and the degree of laxity, not by a fixed count.
Anesthesia and recovery
Office-based. Local anesthesia or air cooling at the operator’s discretion. Recovery time varies according to treatment area, treatment parameters and individual patient response.
Layering onto what you already own
Endolifting is frequently combined with non-ablative fractional resurfacing and injectables. It adds a revenue line to an existing room rather than requiring a new one.
Training and protocol support
Structured online modules and hands-on sessions for operators, plus protocol development support. Parameter presets by treatment area ship loaded on the console and remain editable by the operator.

Procedure footage, filmed in clinic and published unedited. The players load only when you press play. Additional case footage, and the full parameter sets behind these clips, are available to qualified clinicians on request.

Treatment parameters are individualized. Treatment parameters should be individualized by a qualified healthcare professional according to treatment area, tissue characteristics, patient factors and applicable clinical protocols. The protocol statements on this page describe the technique as published by the manufacturer and are indicative only — they must be adapted to your local instructions for use, your training and your own clinical judgement.

For distributors, importers & brand owners

Discuss distribution, OEM or private label.

GigaaMed supports qualified distributors, importers and OEM/private-label partners with product configuration, regulatory documentation, training and technical support.

01 / OEM & PRIVATE LABEL

Your brand on the housing

Your logo, your model name, your documentation package and your own treatment-menu naming — on hardware, firmware and packaging we control end to end.

02 / TERRITORY

Territory protection

Exclusive and semi-exclusive agreements available by region, with defined onboarding volume and a renewal basis agreed up front rather than renegotiated after you have built the market.

03 / SUPPLY

Supply and consumables

Distributor pricing tiers are set by volume. Fibers and accessories ship on the same schedule as the console, so clinics can standardise on a single supplier.

04 / COMPLIANCE

Regulatory documentation

The CE mark, ISO 13485 certificate, MDSAP audit material and the FDA 510(k) K241791 clearance file for the VELAS Pro-30B15D, which includes laser-assisted lipolysis among its cleared indications. Market-specific packs on request.

05 / ENABLEMENT

Training for your team

Factory training and online modules for your service engineers and clinical specialists. Protocol presets ship with the unit, and you get a documented escalation path back to the people who built it.

06 / DEMAND

Marketing assets you can localize

Case photography, treatment protocols, clinical guides and a prepared technical comparison against the incumbent European brand — supplied under the relevant physician authorizations so you can publish without inventing claims.

How a partnership starts

01

Inquiry

Tell us your market, the indications you want to cover and your expected volume.

02

Market & partner evaluation

We review territory coverage, your regulatory situation and the fit on both sides.

03

Product & regulatory review

Configuration, labeling and the documentation your market requires.

04

Training & commercial setup

Team training, pricing structure and the terms of the agreement.

05

Launch & technical support

Launch material, regional spare-part stock and a direct route to the factory engineers.

After the sale

ServiceLocal support in 5 regionsRegional technical support across Europe, the Americas, the Middle East and Asia, with spare-part stock held regionally rather than shipped from Wuhan on demand.
EscalationDirect line to the factoryTechnical escalations route to the engineers who built the platform. No distributor-in-the-middle for a fault you cannot diagnose.
RegulatoryMarket documentation packsWe supply what your regulator asks for: CE documentation, ISO 13485 certificate, MDSAP audit material and the FDA 510(k) file, prepared per market.
GrowthA platform you can extendThe same fiber ecosystem carries into the LASEVIA multi-wavelength platform as your market expands — so the accessories your clinics already stock stay usable.
Fiber ecosystem

Multiple fiber options for different clinical applications.

Fiber selection follows the treatment area, the tissue plane and the clinical application. Every option shares one universal SMA 905 port, so a single accessory shelf covers every configuration you install.

FiberTypical application
200 µmFine and superficial applications, thin skin
400 µmFacial and neck applications
600 µmSelected body and deeper tissue applications
1000 µmLarger-volume adipose planes
Radial / non-contactSpecialty clinical applications — radial emission, and focus or fractional tips
Fiber interfaceSMA 905
Contact fibers200 / 400 / 600 / 1000 µm
Non-contactFocus and fractional tips
SupplySingle-use and reusable

The fiber port is not proprietary. Because the interface is a published industry standard, you can qualify consumables from more than one supplier and price them competitively — so a supply interruption never strands a machine you have already installed. We supply fibers ourselves, with spare stock held regionally.

Handpiece and delivery sets, LVR and proctology accessories, SUPERSCAN focus and fractional handpieces, and the clinic tool set are optional or specialty accessories, not standard configuration. The standard scope of supply depends on the model and the market — confirm it in your quotation. Fiber pricing depends on caliber, volume and territory, so we send the current list alongside the unit quotation.

Questions buyers actually ask

Straight answers.

What is a 980nm + 1470nm laser lift system?

A dual-wavelength diode laser platform that delivers controlled photothermal energy below the skin surface through a fine optical fiber. Both wavelengths share one console and one fiber port, and the clinician selects the wavelength according to the treatment objective and tissue plane.

How do 980nm and 1470nm wavelengths work?

980nm is absorbed by both hemoglobin and water, and supports controlled coagulation and photothermal interaction in soft tissue. 1470nm has substantially higher water absorption, which suits dermal and subdermal applications where the target is tissue water rather than pigment.

What applications can this laser system support?

Depending on configuration, clearance and market: subdermal skin tightening and tissue remodeling, and laser-assisted lipolysis, which is among the cleared indications under FDA 510(k) K241791. Fibers and handpieces adapt the same platform to further clinical applications.

Is the system FDA cleared?

The applicable device configuration is covered by FDA 510(k) K241791. The model cleared at 980nm or 1470nm, VELAS Pro-30B15D, sits under product code GEX (21 CFR 878.4810, Class II). Its cleared indications include surgical applications requiring vaporization, incision, excision, ablation, cutting and hemostasis or coagulation of soft tissue, and laser-assisted lipolysis.

Aesthetic skin tightening or lifting should not be represented as an FDA-cleared indication. We do not claim it is. In the EU both models are CE marked and built under an ISO 13485 quality system audited to MDSAP.

What fibers are available?

200 / 400 / 600 / 1000 µm contact fibers, plus radial and non-contact focus or fractional tips, all on one SMA 905 port. Ask for the complete fiber catalog with your quotation.

Can GigaaMed provide OEM/private-label laser systems?

Yes. GigaaMed supports qualified OEM and private-label partners, subject to product configuration, regulatory and commercial requirements. That covers your logo, your model name, your housing branding and your own documentation package.

What training and technical support are available?

Structured online modules, hands-on sessions at the factory or on site, and protocol development support are available for qualified partners and healthcare professionals, subject to market and regulatory requirements.

This page is written for distributors, importers and licensed clinicians. We do not advise patients or recommend practitioners — if you are seeking treatment, please consult a qualified physician in your own area.

Next step

Ready to discuss Endolifting?

Tell us your market and what you need. We reply from a real address within one business day — not an automated funnel.

Direct contact

Export & distributor enquiriesinfo@gigaamedical.com
ManufacturerGigaaMed
Manufacturing since2005
CertificationCE · MDSAP · ISO 13485 · FDA 510(k) K241791

We do not share your details with third parties. We will not add you to a mailing list you did not ask for.

Enquiry form











    GigaaMed

    GigaaMed — Gigaalaser Company, Ltd. — original equipment manufacturer of medical and aesthetic diode laser systems since 2005. OEM and ODM partner to international laser brands since 2010.